• Triple Refractory Multiple Myeloma Therapeutics Market Size openPR.com Wed, 09 Apr 2025 07:00:00 GMT
• terns pharmaceuticals appoints andrew gengos as chief financial officer The Manila Times Tue, 25 Feb 2025 08:00:00 GMT
• terns pharmaceuticals appoints andrew gengos as chief financial officer wicz.com Mon, 24 Feb 2025 21:12:00 GMT
• Can This Former Amgen VP Transform Terns Pharmaceuticals as New CFO? Stock Titan Mon, 24 Feb 2025 08:00:00 GMT
• light horse: $62 million (series a) raised for developing small molecule therapeutics Pulse 2.0 Thu, 16 Jan 2025 08:00:00 GMT
• New biotech Light Horse snags $1B+ Novartis pact on launch day FirstWord Pharma Thu, 09 Jan 2025 08:00:00 GMT
• Breakpoint Therapeutics presents new POLθ inhibitors BioWorld MedTech Fri, 27 Sep 2024 07:00:00 GMT
• cyteir therapeutics announces the appointment of stephen sands to board of directors Quantisnow Wed, 03 Jul 2024 05:35:15 GMT
• roblox stock: industry expert explains why wall street is wrong Investing.com Fri, 10 May 2024 07:00:00 GMT
• insiders who bought cyteir therapeutics, inc. (nasdaq:cyt) last year must be regretting not buying more as market ... Yahoo News Canada Tue, 30 Apr 2024 08:31:02 GMT
• insiders who bought cyteir therapeutics, inc. (nasdaq:cyt) last year must be regretting not buying more as market ... Yahoo News Canada Thu, 25 Apr 2024 15:24:53 GMT
• incyte signs deal to acquire escient pharmaceuticals Pharmaceutical Technology Wed, 24 Apr 2024 07:00:00 GMT
• great news for cyteir therapeutics, inc. (nasdaq:cyt): insiders acquired stock in large numbers last year Yahoo Movies UK Mon, 25 Mar 2024 10:29:36 GMT
• cyteir therapeutics executive buys $503k in company stock by investing.com Investing.com Mon, 25 Mar 2024 07:00:00 GMT
• cyteir therapeutics formalizes dissolution and asset payout plan TipRanks Wed, 20 Mar 2024 07:00:00 GMT
• cyteir therapeutics executive buys $342k in company stock Investing.com Tue, 19 Mar 2024 07:00:00 GMT
• insiders who bought cyteir therapeutics, inc. (nasdaq:cyt) last year must be regretting not buying more as market ... Yahoo Movies UK Tue, 12 Mar 2024 19:52:08 GMT
• Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq Business Wire Thu, 07 Mar 2024 08:00:00 GMT
• cyteir therapeutics to delist from nasdaq by investing.com Investing.com Thu, 07 Mar 2024 08:00:00 GMT
• will cyteir therapeutics inc (cyt) stay at the top of the healthcare sector? InvestorsObserver Tue, 16 Jan 2024 16:22:01 GMT
• is cyteir therapeutics inc (cyt) a good choice in biotechnology thursday? InvestorsObserver Thu, 11 Jan 2024 15:50:42 GMT
• the definitive boston biotech layoff tracker for 2023 The Business Journals Tue, 02 Jan 2024 08:00:00 GMT
• head and neck cancer pipeline analysis report by delveinsight | investigating fda approvals, clinical trials, openPR Thu, 14 Dec 2023 08:00:00 GMT
• biopharma layoff tracker 2023: pfizer, orna, kite and more cut staff BioSpace Fri, 01 Dec 2023 08:00:00 GMT
• adavosertib enhances antitumor activity of trastuzumab ... Cancer Discovery Wed, 01 Nov 2023 07:18:32 GMT
• spop mutations target sting1 signaling in prostate cancer and ... Cancer Discovery Wed, 01 Nov 2023 07:18:23 GMT
• durvalumab plus carboplatin/paclitaxel followed by maintenance ... ASCO Journals Sat, 21 Oct 2023 07:00:00 GMT
• cyt-0851 plus capecitabine demonstrates efficacy in advanced ovarian cancer OncLive Thu, 12 Oct 2023 07:00:00 GMT
• ongoing results from a dose expansion cohort of cyt-0851 in combination with capecitabine in advanced ... Business Wire Thu, 12 Oct 2023 07:00:00 GMT
• biotech layoffs 2023: massachusetts hit hard after years of hype The Boston Globe Tue, 10 Oct 2023 07:00:00 GMT
• mypathway human epidermal growth factor receptor 2 basket ... ASCO Journals Wed, 04 Oct 2023 07:00:00 GMT
• canakinumab as adjuvant therapy in patients with completely ... ASCO Journals Tue, 03 Oct 2023 07:00:00 GMT
• tiragolumab alone or with atezolizumab in patients with advanced ... JAMA Network Thu, 28 Sep 2023 07:00:00 GMT
• phase 1 study of jnj-64619178, a protein arginine ... Cancer Discovery Fri, 15 Sep 2023 08:21:48 GMT
• epitope editing enables targeted immunotherapy of acute myeloid ... Nature.com Wed, 30 Aug 2023 07:00:00 GMT
• athira pharma reports second quarter 2023 financial results and pipeline and business updates Yahoo Finance Thu, 10 Aug 2023 07:00:00 GMT
• inovio stock gains on restructuring drive (nasdaq:ino) Seeking Alpha Tue, 01 Aug 2023 07:00:00 GMT
• phase ii study of olaparib and temozolomide for advanced uterine ... ASCO Journals Wed, 19 Jul 2023 07:00:00 GMT
• premarket mover: cyteir therapeutics inc (cyt) up 1.54% InvestorsObserver Mon, 03 Jul 2023 07:00:00 GMT
• mass. biotech ipo market pick back up in 2023? - boston business ... The Business Journals Mon, 03 Jul 2023 07:00:00 GMT
• my thoughts on the liquidation value of cyteir therapeutics substack.com Sat, 01 Jul 2023 07:00:00 GMT
• biotech’s drug flop turns into boon for investors on cash return BNN Bloomberg Fri, 30 Jun 2023 18:09:54 GMT
• Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution Business Wire Fri, 30 Jun 2023 07:00:00 GMT
• Two years after IPO, a Lexington biotech shuts down The Business Journals Fri, 30 Jun 2023 07:00:00 GMT
• cyteir finally calls it quits after months of cost cutting Fierce Biotech Fri, 30 Jun 2023 07:00:00 GMT
• biotech cyteir’s drug flop turns into boon for investors on cash return Bloomberg Fri, 30 Jun 2023 07:00:00 GMT
• cyteir therapeutics (nasdaq: cyt) to dissolve after discontinuing development of cyt-0851 Financial Content Fri, 30 Jun 2023 07:00:00 GMT
• cyteir (cyt) stock surges after announcing plans to dissolve Bloomberg Fri, 30 Jun 2023 07:00:00 GMT
• cyteir therapeutics dissolves the end of an era for monocarboxylate transporter inhibitors Best Stocks Fri, 30 Jun 2023 07:00:00 GMT
• should you add cyteir therapeutics inc (cyt) stock to your portfolio thursday? InvestorsObserver Thu, 29 Jun 2023 07:00:00 GMT
• emergent biosolutions appoints miller interim ceo (nyse:ebs) Seeking Alpha Tue, 27 Jun 2023 07:00:00 GMT
• dianthus therapeutics appoints adam veness, esq., as general counsel citybiz Tue, 20 Jun 2023 07:00:00 GMT
• biopharma layoff tracker 2023: rejuvenate, greenlight biosciences ... PharmaLive Wed, 14 Jun 2023 07:00:00 GMT
• mirvetuximab soravtansine data 'practice changing' for subset of ... Healio Mon, 12 Jun 2023 07:00:00 GMT
• camonsertib in dna damage response-deficient advanced solid ... Nature.com Mon, 05 Jun 2023 07:00:00 GMT
• mirvetuximab soravtansine yields disease reduction in frα+ ... Cancer Network Sun, 04 Jun 2023 07:00:00 GMT
• may 25, 2023 - supplement: conference highlights sgo 2023 ... The ASCO Post Thu, 25 May 2023 07:00:00 GMT
• tech moves: realnetworks appoints president; microsoft alumni network leader to step down GeekWire Wed, 24 May 2023 07:00:00 GMT
• biopharma layoff tracker 2023: urovant, genedx, adaptive phage ... PharmaLive Fri, 19 May 2023 07:00:00 GMT
• fusion and cyteir refocus pipelines; nona biosciences collaborating with pharmaessentia Endpoints News Fri, 12 May 2023 07:00:00 GMT
• gritstone, mei join biotechs using earnings season to reshuffle pipeline priorities Fierce Biotech Fri, 12 May 2023 07:00:00 GMT
• wedbush analyst reiterates outperform rating for cyteir therapeutics with 3 price target Best Stocks Fri, 12 May 2023 07:00:00 GMT
• Fusion, Cyteir refocus pipelines to funnel cash toward best bets Fierce Biotech Thu, 11 May 2023 07:00:00 GMT
• cyteir therapeutics reports first quarter 2023 financial results and operational highlights Business Wire Wed, 10 May 2023 07:00:00 GMT
• layoff tracker 2023: cepheid, care access, thermo fisher scientific ... PharmaLive Tue, 02 May 2023 07:00:00 GMT
• impact of biomarker-matched therapies on outcomes in patients ... Cancer Discovery Mon, 01 May 2023 08:09:08 GMT
• repare therapeutics appoints susan molineaux, ph.d., to its board ... Business Wire Fri, 28 Apr 2023 07:00:00 GMT
• long-term outcomes and molecular correlates of sotorasib ... ASCO Journals Tue, 25 Apr 2023 07:00:00 GMT
• insiders who bought cyteir therapeutics, inc. (nasdaq:cyt) last year must be regretting not buying more as market ... Yahoo News Canada Thu, 20 Apr 2023 07:00:00 GMT
• national cancer institute combination therapy platform trial with ... Cancer Discovery Fri, 14 Apr 2023 08:11:00 GMT
• biotech layoffs 2023: about 1500 mass. workers were laid off in q1 - boston business journal The Business Journals Mon, 03 Apr 2023 07:00:00 GMT
• cyteir therapeutics reports fourth quarter and full year 2022 financial results and operational highlights Business Wire Thu, 23 Mar 2023 07:00:00 GMT
• the menin inhibitor revumenib in kmt2a-rearranged or npm1 ... Nature.com Wed, 15 Mar 2023 07:00:00 GMT
• a phase 1 first-in-human study of fs118, a tetravalent bispecific ... Cancer Discovery Wed, 01 Mar 2023 08:14:51 GMT
• chutes & ladders—former roche pharma chief tapped to be new bayer ceo Fierce Biotech Fri, 10 Feb 2023 08:00:00 GMT
• layoffs and shutdowns hit biotech industry in u-turn The Wall Street Journal Fri, 10 Feb 2023 08:00:00 GMT
• see the startups that laid off more than 3,000 workers this year Business Insider Tue, 07 Feb 2023 08:00:00 GMT
• cyteir therapeutics appoints david gaiero finance chief Marketscreener.com Mon, 06 Feb 2023 13:49:29 GMT
• Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer citybiz Mon, 06 Feb 2023 08:00:00 GMT
• should biotechnology stock cyteir therapeutics inc (cyt) be in your portfolio tuesday? InvestorsObserver Tue, 31 Jan 2023 08:00:00 GMT
• cyteir therapeutics downgraded to neutral at bofa on pipeline prioritization (nasdaq:cyt) Seeking Alpha Mon, 30 Jan 2023 08:00:00 GMT
• money moves: how the biotech market is weathering inflationary ... Pharmaceutical Technology Thu, 26 Jan 2023 08:00:00 GMT
• microbiome firm finch therapeutics cuts 95 percent of its workforce The Boston Globe Tue, 24 Jan 2023 08:00:00 GMT
• merck kgaa shrinks us research team as layoffs continue to batter ... FierceBiotech Mon, 23 Jan 2023 08:00:00 GMT
• cyteir lays off 70% of workforce after further narrowing cancer drug goals Fierce Biotech Fri, 20 Jan 2023 08:00:00 GMT
• cyteir therapeutics lays off 70%, extends cash runway into 2026 MM+M Online Fri, 20 Jan 2023 08:00:00 GMT
• cyteir lays off 70% after further narrowing cancer drug goals Fierce Biotech Fri, 20 Jan 2023 08:00:00 GMT
• Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway Business Wire Thu, 19 Jan 2023 08:00:00 GMT
• fierce biotech layoff tracker 2023: gilead's kite cuts 7% in refocus ... FierceBiotech Mon, 09 Jan 2023 19:24:18 GMT
• ccar2 functions downstream of the shieldin complex to promote ... pnas.org Tue, 29 Nov 2022 08:00:00 GMT
• alexion's new u.s. head is looking for 'the next generation of ... The Business Journals Tue, 22 Nov 2022 08:00:00 GMT
• phase ia/b, open-label, multicenter study of azd4635 (an ... Cancer Discovery Mon, 14 Nov 2022 08:29:08 GMT
• great news for cyteir therapeutics, inc. (nasdaq:cyt): insiders acquired stock in large numbers last year Yahoo Movies UK Sat, 22 Oct 2022 07:00:00 GMT
• randomized trial of olaparib with or without cediranib for ... ASCO Journals Tue, 18 Oct 2022 07:00:00 GMT
• targeting dna repair with combined inhibition of nhej and mmej ... Cancer Discovery Mon, 17 Oct 2022 08:12:02 GMT
• head and neck cancer clinical trial pipeline: analysis of 130+ key companies working in the domain | delveinsight GlobeNewswire Mon, 10 Oct 2022 07:00:00 GMT
• cyteir therapeutics receives investment bank analyst rating update by investing.com Investing.com Australia Fri, 09 Sep 2022 07:00:00 GMT
• overall survival with maintenance olaparib at a 7-year follow-up ... ASCO Journals Fri, 09 Sep 2022 07:00:00 GMT
• first-in-human phase i/ii iconic trial of the icos agonist ... Cancer Discovery Fri, 02 Sep 2022 05:25:33 GMT
• targeting the dna damage response pathways and replication ... Cancer Discovery Thu, 01 Sep 2022 14:39:25 GMT
• Member Spotlight: Q&A with Cyteir Therapeutics Massachusetts Biotechnology Council Thu, 01 Sep 2022 07:00:00 GMT
• cyteir therapeutics to participate in the morgan stanley 20th annual global healthcare conference Business Wire Wed, 31 Aug 2022 07:00:00 GMT
• patient-reported symptom burden in patients with rare cancers ... Nature.com Tue, 23 Aug 2022 07:00:00 GMT
• cyteir pauses development of cancer med, funnels cash toward lead asset Fierce Biotech Tue, 09 Aug 2022 07:00:00 GMT
• cyteir therapeutics reports second quarter 2022 financial results and operational highlights BioSpace Mon, 08 Aug 2022 07:00:00 GMT
• phase ii study of enzalutamide for patients with androgen receptor ... ASCO Journals Fri, 22 Jul 2022 07:00:00 GMT
• ca-125 kelim as a potential complementary tool for predicting ... ASCO Journals Fri, 22 Jul 2022 07:00:00 GMT
• therapy for stage iv non–small-cell lung cancer with driver ... ASCO Journals Mon, 11 Jul 2022 07:00:00 GMT
• cyteir therapeutics, inc. : other events, financial statements ... Marketscreener.com Mon, 06 Jun 2022 07:00:00 GMT
• a randomized, phase iii trial to evaluate rucaparib monotherapy ... ASCO Journals Mon, 06 Jun 2022 07:00:00 GMT
• cyt-0851 phase 1 dose escalation results show early clinical activity and generally well tolerated safety profile in ... Business Wire Sun, 05 Jun 2022 07:00:00 GMT
• phase ib/ii study of enzalutamide with samotolisib (ly3023414) or ... Cancer Discovery Wed, 01 Jun 2022 08:29:33 GMT
• morgan stanley lists biotechs with negative enterprise value, 2022 ... Seeking Alpha Mon, 30 May 2022 07:00:00 GMT
• next-generation parp1-selective inhibitor offers significant ... The ASCO Post Wed, 25 May 2022 07:00:00 GMT
• chutes & ladders—biogen ceo vounatsos steps down amid ... FierceBiotech Fri, 06 May 2022 07:00:00 GMT
• cyteir therapeutics inc stock quote | stock price for cyt | financialcontent business page Financial Content Fri, 06 May 2022 05:57:41 GMT
• cyteir therapeutics reports first quarter 2022 financial results and operational highlights Business Wire Thu, 05 May 2022 07:00:00 GMT
• cyteir therapeutics names krisztina nemenyi as senior vice president of regulatory affairs and quality Business Wire Tue, 03 May 2022 07:00:00 GMT
• cyteir therapeutics appoints krisztina nemenyi as senior vice president citybiz Tue, 03 May 2022 07:00:00 GMT
• phase ib study of navicixizumab plus paclitaxel in patients with ... ASCO Journals Tue, 19 Apr 2022 07:00:00 GMT
• cyteir therapeutics reports fourth quarter and full year 2021 financial results and operational highlights Business Wire Wed, 16 Mar 2022 07:00:00 GMT
• a phase 1a/b open-label, dose-escalation study of etigilimab ... Cancer Discovery Thu, 03 Mar 2022 08:23:59 GMT
• cyteir therapeutics announces the appointment of stephen sands to board of directors Business Wire Thu, 24 Feb 2022 08:00:00 GMT
• long-term survival benefit in nsclc with another anti-pd-1/l1 drug Medpage Today Tue, 15 Feb 2022 08:00:00 GMT
• cyteir therapeutics announces the appointment of john f. thero to board of directors Business Wire Mon, 07 Feb 2022 08:00:00 GMT
• cyteir therapeutics appoints john f. thero to board of directors citybiz Mon, 07 Feb 2022 08:00:00 GMT
• trametinib versus standard of care in patients with recurrent low ... The Lancet Sat, 05 Feb 2022 08:00:00 GMT
• five-year survival outcomes from the pacific trial: durvalumab ... ASCO Journals Wed, 02 Feb 2022 08:00:00 GMT
• ipos had a record 2021. now they are selling off like crazy. The Wall Street Journal Wed, 29 Dec 2021 08:00:00 GMT
• Cyteir Therapeutics Appoints Dr. Jeffrey S. Humphrey to Board citybiz Thu, 16 Dec 2021 08:00:00 GMT
• how newly public firms responded to questions on diversity The Business Journals Thu, 14 Oct 2021 07:00:00 GMT
• lack of transparency at the top of newly public companies - boston ... The Business Journals Thu, 14 Oct 2021 07:00:00 GMT
• cyteir therapeutics selected to join russell 2000® index Business Wire Mon, 20 Sep 2021 07:00:00 GMT
• lightstone ventures raises $375m fund to invest in early stage biotech and medtech companies HIT Consultant Tue, 14 Sep 2021 07:00:00 GMT
• july m&a: a wicked good acquisition, and perkinelmer's $5.25b ... The Business Journals Tue, 03 Aug 2021 07:00:00 GMT
• first‐in‐human, first‐in‐class, phase i trial of the fucosylation ... The Oncologist Tue, 20 Jul 2021 07:00:00 GMT
• lowell microbial testing startup lands its ipo - boston business ... The Business Journals Thu, 15 Jul 2021 07:00:00 GMT
• the daily biotech pulse: spero spikes on pfizer investment, fda nod for jazz, orchard signs licensing deal ... Markets Insider Thu, 01 Jul 2021 07:00:00 GMT
• Cyteir Therapeutics Announces Closing of Initial Public Offering Business Wire Tue, 22 Jun 2021 07:00:00 GMT
• shares of cancer biotech cyteir down after $133m ipo The Business Journals Mon, 21 Jun 2021 07:00:00 GMT
• peter thiel’s atai life sciences and 5 other companies list shares Barron's Fri, 18 Jun 2021 07:00:00 GMT
• peter thiel's atai life sciences and 5 other companies list shares Barron's Fri, 18 Jun 2021 07:00:00 GMT
• ipo news - us ipo weekly recap: ipo market in full swing as biotechs lead a 16 ipo week Renaissance Capital Fri, 18 Jun 2021 07:00:00 GMT
• 6 software companies that are beating chip stocks this year Barron's Fri, 18 Jun 2021 07:00:00 GMT
• oncology biotech cyteir therapeutics prices ipo at $18 high end Renaissance Capital Fri, 18 Jun 2021 07:00:00 GMT
• cyt - cyteir therapeutics, inc. latest stock news & market updates StockTitan Thu, 17 Jun 2021 23:16:05 GMT
• push to public continues as biotech dominates the ipo list this week BioSpace Thu, 17 Jun 2021 07:00:00 GMT
• a recent flurry of biotech ipos: lyell, atai, alzamend and more BioSpace Wed, 09 Jun 2021 07:00:00 GMT
• Day 1 ASCO 2021 Roundup: Combating Lung Cancer, Hematologic Malignancies and Advanced Solid Tumors geneonline.com Sat, 05 Jun 2021 07:00:00 GMT
• Cyteir Therapeutics Announces Presentation of First-in-Human Phase 1/2 Study of CYT-0851 PR Newswire Fri, 04 Jun 2021 07:00:00 GMT
• cyt ipo news - oncology biotech cyteir therapeutics files for a $100 million ipo Renaissance Capital Fri, 28 May 2021 07:00:00 GMT
• Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares Barron's Mon, 10 May 2021 07:00:00 GMT
• astrazeneca covid vaccine inventor vaccitech's ipo prices ... Seeking Alpha Thu, 29 Apr 2021 07:00:00 GMT
• vaxart is soaring on more than 10 times the two-month average ... Seeking Alpha Tue, 27 Apr 2021 07:00:00 GMT
• Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program PR Newswire Thu, 11 Feb 2021 08:00:00 GMT
• Cancer biotech Cyteir raises $80M, plans to double headcount this year The Business Journals Thu, 11 Feb 2021 08:00:00 GMT
• healthcare startups poised to take off, according to top vcs Business Insider Tue, 22 Dec 2020 08:00:00 GMT
• folfoxiri‐bevacizumab or folfox‐panitumumab in patients ... The Oncologist Fri, 18 Dec 2020 08:00:00 GMT
• Cyteir Therapeutics Advances Clinical Trial of Lead RAD51 Synthetic Lethality Program in Cancer and Expands Senior Leadership Team... PR Newswire Tue, 07 Jul 2020 07:00:00 GMT
• gsk dives deeper into synthetic lethality with ideaya biosciences BioSpace Tue, 16 Jun 2020 07:00:00 GMT
• lexington biotech property sells for $112m - boston business journal The Business Journals Wed, 26 Feb 2020 08:00:00 GMT
• cyteir therapeutics nets $40 million, plus more top funding news for cambridge-based companies Yahoo! Voices Fri, 25 Oct 2019 07:00:00 GMT
• exploring synthetic lethal cancer drug discovery: barbara weber on the long run Timmerman Report Thu, 01 Nov 2018 07:00:00 GMT
• the top silicon valley biotech venture capitalists and investors Business Insider Sat, 15 Sep 2018 07:00:00 GMT
• free biotech stocks directory, pharma stocks, telemedicine stocks ... InvestorIdeas.com Thu, 30 Aug 2018 18:22:11 GMT
• 'samen met de rockefellers en google gaan we strijd met kanker aan' De Tijd Fri, 23 Mar 2018 07:00:00 GMT
• inside a tiny cambridge biotech’s plot to make cancer self-destruct The Business Journals Thu, 08 Mar 2018 08:00:00 GMT
• cyteir reels in $29m to target dna repair in cancer, autoimmune disease Fierce Biotech Thu, 08 Mar 2018 08:00:00 GMT
• cambridge cancer drug biotech cyteir therapeutics raises $29m series b round The Business Journals Thu, 08 Mar 2018 08:00:00 GMT
• researchers block b-cell aid, prevent diabetes in nod mice Medical Xpress Thu, 01 Jun 2017 07:00:00 GMT
Cyteir Therapeutics Inc(NASDAQ:CYT) 
Through a unique cancer treatment approach, Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell ...
Share this website to your friends